|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51979024
線上人數 :
1191
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"jean s s"的相關文件
顯示項目 111-120 / 136 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2019 |
Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
|
PO-REN HSUEH; Lee W.-S.; Hsueh S.-C.; Jean S.-S.; PO-REN HSUEH;Lee W.-S.;Hsueh S.-C.;Jean S.-S. |
| 臺大學術典藏 |
2019 |
Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci
|
Jean S.-S.;Hsueh S.-C.;Hwang J.-J.;Po-Ren Hsueh; Jean S.-S.; Hsueh S.-C.; Hwang J.-J.; PO-REN HSUEH |
| 臺大學術典藏 |
2019 |
Corrigendum to “Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia” (Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia (2017) 50(4) (547–548), (S1684118216300299), (10.1016/j.jmii.2016.03.008))
|
Lee W.-S.;Po-Ren Hsueh;Hsieh T.-C.;Chen F.-L.;Ou T.-Y.;Jean S.-S.; Lee W.-S.; PO-REN HSUEH; Hsieh T.-C.; Chen F.-L.; Ou T.-Y.; Jean S.-S. |
| 臺大學術典藏 |
2019 |
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
|
Jean S.-S.;Gould I.M.;Lee W.-S.;Po-Ren Hsueh;International Society Of Antimicrobial Chemotherapy (Isac); Jean S.-S.; Gould I.M.; Lee W.-S.; PO-REN HSUEH; International Society of Antimicrobial Chemotherapy (ISAC) |
| 臺大學術典藏 |
2018 |
Corrigendum to “Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam” [J Microbiol Immunol Infect (2017) 50: 454–463](S1684118215008476)(10.1016/j.jmii.2015.08.024)
|
PO-REN HSUEH;Lee W.-S.;Sheng W.-H.;Liao C.-H.;Jean S.-S.; Jean S.-S.; Liao C.-H.; Sheng W.-H.; Lee W.-S.; PO-REN HSUEH |
| 臺大學術典藏 |
2018 |
Carbapenem-resistant enterobacteriaceae infections: Taiwan aspects
|
Jean S.-S.;Lee N.-Y.;Tang H.-J.;Lu M.-C.;Ko W.-C.;Po-Ren Hsueh; Jean S.-S.; Lee N.-Y.; Tang H.-J.; Lu M.-C.; Ko W.-C.; PO-REN HSUEH |
| 臺大學術典藏 |
2018 |
Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the enterobacteriaceae isolates causing intra-abdominal infections in the asia-pacific region: Results from the study for monitoring antimicrobial resistance trends (SMART)
|
Jean S.-S.;Lee W.-S.;Po-Ren Hsueh;Smart Asia-Pacific Group; Jean S.-S.; Lee W.-S.; PO-REN HSUEH; SMART Asia-Pacific Group |
| 臺大學術典藏 |
2018 |
Corrigendum to “Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam” [J Microbiol Immunol Infect (2017) 50: 454–463](S1684118215008476)(10.1016/j.jmii.2015.08.024)
|
PO-REN HSUEH; Lee W.-S.; Sheng W.-H.; Liao C.-H.; Jean S.-S.; Jean S.-S.;Liao C.-H.;Sheng W.-H.;Lee W.-S.;Po-Ren Hsueh |
| 國立成功大學 |
2018 |
Carbapenem-resistant enterobacteriaceae infections: Taiwan aspects
|
Jean, S.-S.;Lee, N.-Y.;Tang, H.-J.;Lu, M.-C.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2018 |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean, S.-S.;Lu, M.-C.;Shi, Z.-Y.;Tseng, S.-H.;Wu, T.-S.;Lu, P.-L.;Shao, P.-L.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R. |
顯示項目 111-120 / 136 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
